World's Best Scientists 2026 revealed!
Nikos K. Karamanos

Nikos K. Karamanos

Award Badge
Biology and Biochemistry
Greece
2025

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
22241
World Ranking
6556
National Ranking
11

Nikos K. Karamanos publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Nikos K. Karamanos sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 353 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Nikos K. Karamanos D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Nikos K. Karamanos sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Biology and Biochemistry in Greece Leader Award
  • 2023 - Research.com Biology and Biochemistry in Greece Leader Award
  • 2022 - Research.com Biology and Biochemistry in Greece Leader Award

Overview

Nikos K. Karamanos is affiliated with the University of Patras in Greece. Their research primarily spans the domains of biochemistry, genetics, and molecular biology, with significant interdisciplinary overlap into medicine.

The main fields of study for Karamanos include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Their subfields of study indicate a focus on:

  • Molecular Biology
  • Oncology
  • Cell Biology
  • Cancer Research
  • Immunology and Allergy

The research topics covered extensively by Karamanos include:

  • Proteoglycans and glycosaminoglycans research
  • Cancer Cells and Metastasis
  • Protease and Inhibitor Mechanisms
  • Cell Adhesion Molecules Research
  • Glycosylation and Glycoproteins Research
  • Fibroblast Growth Factor Research
  • Extracellular vesicles in disease

Frequent publication venues reflect the scientist's participation in journals with a focus on molecular biology and cancer research:

  • FEBS Journal
  • Cancers
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Molecular Biology Reports
  • Matrix Biology Plus

Karamanos has collaborated extensively with co-authors frequently appearing alongside their work, including:

  • Zoi Piperigkou
  • Séamus J. Martin
  • Dublin Chair
  • Andrey Abramov
  • Colin Adrain

Recent publications demonstrate a sustained interest in the extracellular matrix and its implications in cancer and cellular biology. Selected recent papers are:

  • "A guide to the composition and functions of the extracellular matrix" (2021, FEBS Journal)
  • "Extracellular matrix-based cancer targeting" (2021, Trends in Molecular Medicine)
  • "Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer" (2021, Cancers)
  • "Epigenetic Alterations in Triple-Negative Breast Cancer-The Critical Role of Extracellular Matrix" (2021, Cancers)
  • "A biological guide to glycosaminoglycans: current perspectives and pending questions" (2024, FEBS Journal)

Best Publications

  • Extracellular matrix structure.

    Achilleas D Theocharis;Spyros S Skandalis;Chrysostomi Gialeli;Nikos K Karamanos

  • Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

    Chrisostomi Gialeli;Achilleas D. Theocharis;Nikos K. Karamanos

  • Glycosaminoglycans: key players in cancer cell biology and treatment

    Nikos Afratis;Chrisostomi Gialeli;Dragana Nikitovic;Theodore Tsegenidis

  • A guide to the composition and functions of the extracellular matrix.

    Nikos K. Karamanos;Achilleas D. Theocharis;Zoi Piperigkou;Dimitra Manou

  • Hyaluronan–CD44 interactions as potential targets for cancer therapy

    Suniti Misra;Paraskevi Heldin;Vincent C. Hascall;Nikos K. Karamanos

  • Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.

    Achilleas D. Theocharis;Spyridon S. Skandalis;George N. Tzanakakis;Nikos K. Karamanos

  • The extracellular matrix as a multitasking player in disease.

    Achilleas D. Theocharis;Dimitra Manou;Nikos K. Karamanos

  • Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer.

    Anastasia G. Tavianatou;Ilaria Caon;Marco Franchi;Zoi Piperigkou;Zoi Piperigkou

  • Derivatization of carbohydrates for chromatographic, electrophoretic and mass spectrometric structure analysis.

    Fotini N Lamari;Reinhard Kuhn;Nikos K Karamanos

  • Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics.

    Nikos K. Karamanos;Nikos K. Karamanos;Zoi Piperigkou;Zoi Piperigkou;Achilleas D. Theocharis;Hideto Watanabe

  • Syndecans – key regulators of cell signaling and biological functions

    Nikolaos A. Afratis;Nikolaos A. Afratis;Dragana Nikitovic;Hinke A. B. Multhaupt;Achilleas D. Theocharis

  • Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases.

    Nikos K. Karamanos;Achilleas D. Theocharis;Thomas Neill;Renato V. Iozzo

  • Inhaled chemotherapy in lung cancer: future concept of nanomedicine

    Paul Zarogoulidis;Ekaterini Chatzaki;Konstantinos Porpodis;Kalliopi Domvri

  • Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.

    Spyros S. Skandalis;Nikolaos Afratis;Gianna Smirlaki;Dragana Nikitovic

  • Inhibition of breast cancer cell proliferation by style constituents of different Crocus species.

    Dimitra G. Chryssanthi;Fotini N. Lamari;Gregoris Iatrou;Adamantia Pylara

  • Proteoglycans remodeling in cancer: Underlying molecular mechanisms.

    Achilleas D. Theocharis;Nikos K. Karamanos

  • Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.

    Evgenia Karousou;Suniti Misra;Shibnath Ghatak;Katalin Dobra

  • Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.

    Panagiotis Bouris;Spyros S. Skandalis;Zoi Piperigkou;Nikos Afratis

  • Recent Advances in the Structural Study of Functional Chondroitin Sulfate and Dermatan Sulfate in Health and Disease

    Christina Malavaki;Shuji Mizumoto;Nikos Karamanos;Kazuyuki Sugahara

  • Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

    Achilleas D. Theocharis;Spyros S. Skandalis;Thomas Neill;Hinke A.B. Multhaupt

Frequent Co-Authors

Achilleas D. Theocharis
Achilleas D. Theocharis University of Patras
George N. Tzanakakis
George N. Tzanakakis University of Crete
Dimitris Kletsas
Dimitris Kletsas National Centre of Scientific Research Demokritos
Aristidis Tsatsakis
Aristidis Tsatsakis University of Crete
Alberto Passi
Alberto Passi University of Insubria
Renato V. Iozzo
Renato V. Iozzo Thomas Jefferson University
Martin Götte
Martin Götte University of Münster
Giovanni Sindona
Giovanni Sindona University of Calabria
Vincent C. Hascall
Vincent C. Hascall Cleveland Clinic
Roger R. Markwald
Roger R. Markwald Medical University of South Carolina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Nikos K. Karamanos

Trending Scientists

Recently Published Articles